International Biotechnology (LON:IBT) Issues Quarterly Earnings Results

International Biotechnology (LON:IBT) issued its quarterly earnings results on Tuesday. The company reported GBX (10.22) earnings per share (EPS) for the quarter, Digital Look Earnings reports. The firm had revenue of GBX 46 million for the quarter. International Biotechnology had a net margin of 82.27% and a return on equity of 27.35%.

International Biotechnology Price Performance

Shares of LON:IBT opened at GBX 1,026.66 on Tuesday. International Biotechnology has a 1-year low of GBX 812 and a 1-year high of GBX 1,235. The firm has a market capitalization of £324.97 million, a PE ratio of 4.25 and a beta of 0.47. The business’s 50 day moving average is GBX 1,080.85 and its 200-day moving average is GBX 1,009.76. The company has a current ratio of 0.11, a quick ratio of 0.32 and a debt-to-equity ratio of 9.43.

International Biotechnology Company Profile

The Company’s investment objective is to achieve long-term capital growth by investing in biotechnology and other life sciences companies.

The Company will seek to achieve its objective by investing in a diversified portfolio of companies which may be quoted or unquoted and whose shares are considered to have good growth prospects, with experienced management and strong potential upside through the development and/or commercialisation of a product, device or enabling technology. Investments may also be made in related sectors such as medical devices and healthcare services.